BAP1 Has a Survival Role in Cutaneous Melanoma

Journal of Investigative Dermatology

Volumn 135, Issue 4, 2015, Pages 1089-1097

  Kumar, Raj ^a   Taylor, Michael ^a   Miao, Benchun ^a   Ji, Zhenyu ^a   Njauw, Jenny C N ^a   Jönsson, Göran ^b   Frederick, Dennie T ^c   Tsao, Hensin ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LUND UNIVERSITY   (Sweden)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 ASSOCIATED PROTEIN 1; PROTEIN; SURVIVIN; UNCLASSIFIED DRUG; BAP1 PROTEIN, HUMAN; BAP1 PROTEIN, MOUSE; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE PREDISPOSITION; MELANOCYTE; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; ANIMAL; CELL CYCLE; CELL SURVIVAL; CYTOLOGY; GENE EXPRESSION REGULATION; HUMAN; MELANOMA; METABOLISM; NONOBESE DIABETIC MOUSE; SCID MOUSE; SKIN TUMOR; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MELANOCYTES; MELANOMA; MICE; MICE, INBRED NOD; MICE, SCID; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84925442599     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.528     Document Type: Article

References (24)

1. Abdel-Rahman MH, Pilarski R, Cebulla CM et al. (2011) Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 48:856-9
2. Bott M, Brevet M, Taylor BS et al. (2011) The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 43:668-72
3. Carbone M, Yang H, Pass HI et al. (2013) BAP1 and cancer. Nat Rev Cancer 13:153-9
4. Dalinghaus M, Rudolph CD, Rudolph AM (1991) Effects of maternal fasting on hepatic gluconeogenesis and glucose metabolism in fetal lambs. J Dev Physiol 16:267-75
5. Dey A, Seshasayee D, Noubade R et al. (2012) Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 337:1541-6
6. Harbour JW, Onken MD, Roberson ED et al. (2010) Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330:1410-3
7. Harbst K, Staaf J, Lauss M et al. (2012) Molecular profiling reveals low- and high-grade forms of primary melanoma. Clin Cancer Res 18:4026-36
8. Jensen DE, Proctor M, Marquis ST et al. (1998) BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16:1097-112
9. Ji Z, Kumar R, Taylor M et al. (2013) Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth. Clin Cancer Res 19:4383-91
10. Ji Z, Njauw CN, Taylor M et al. (2012) p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition. J Investig Dermatol Symp Proc 132:356-64
11. Katja H, Johan S, Martin L et al. (2012) Molecular profiling reveals low- and high-grade forms of primary melanoma. Clin Cancer Res 18:4026-36
12. Kittler R, Pelletier L, Heninger AK et al. (2007) Genome-scale RNAi profiling of cell division in human tissue culture cells. Nat Cell Biol 9:1401-12
13. Machida YJ, Machida Y, Vashisht AA et al. (2009) The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem 284:34179-88
14. Matatall KA, Agapova OA, Onken MD et al. (2013) BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma. BMC Cancer 13:371
15. McKenzie JA, Grossman D (2012) Role of the apoptotic and mitotic regulator survivin in melanoma. Anticancer Res 32:397-404
16. Murali R, Wilmott JS, Jakrot V et al. (2013) BAP1 expression in cutaneous melanoma: a pilot study. Pathology 45:606-9
17. Njauw CN, Kim I, Piris A et al. (2012) Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous- ocular melanoma families. PloS One 7:e35295
18. Pena-Llopis S, Vega-Rubin-de-Celis S, Liao A et al. (2012) BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 44:751-9
19. Schlabach MR, Luo J, Solimini NL et al. (2008) Cancer proliferation gene discovery through functional genomics. Science 319:620-4
20. Shah AA, Bourne TD, Murali R (2013) BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Pathology 45:651-6
21. Testa JR, Cheung M, Pei J et al. (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43:1022-5
22. Udayakumar D, Zhang G, Ji Z et al. (2011) Epha2 is a critical oncogene in melanoma. Oncogene 30:4921-9
23. Wiesner T, Obenauf AC, Murali R et al. (2011) Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43:1018-21
24. Yu H, Mashtalir N, Daou S et al. (2010) The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol Cell Biol 30:5071-85